AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
[ILLUSTRATION OMITTED]
The U.S. Food and Drug Administration (FDA) approved the first generic versions of the popular osteoporosis drug Fosamax (alendronate) on February 6, 2008. Fosamax, made by Merck & Co., is among the top 100 most frequently dispensed drugs in the united states. Currently Fosamax costs $80 to $85 per month. Although generic drugs are chemically identical to their branded counterparts, they are sold at substantial discounts. Teva Pharmaceuticals USA will manufacture the generic ...